Full text

Turn on search term navigation

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Myopia is the most common refractive error worldwide. This cannot be explained by genetic factors alone, therefore, environmental factors may play an important role. Hence, the main objective of this study was to analyse whether outdoor exposure could exert a protective effect against the development of myopia in a cohort of young adults and to investigate ultraviolet autofluorescence (CUVAF), as a biomarker of time spent outdoors. A cross-sectional observational study was carried out using two cohorts. A total of 208 participants were recruited, 156 medical students and 52 environmental science students. The data showed that 66.66% of the medical students were myopic, while 50% of the environmental science students were myopic (p = 0.021). Environmental science students spent significantly more hours per week doing outdoor activities than medical students (p < 0.0001), but there was no significant difference with respect to near work activities between them. In both cohorts, the degree of myopia was inversely associated with CUVAF, and a statistically significant positive correlation was observed between spherical equivalent and CUVAF (Pearson’s r = 0.248). In conclusion, outdoor activities could reduce the onset and progression of myopia not only in children, but also in young adults. In addition, CUVAF represents an objective, non-invasive biomarker of outdoor exposure that is inversely associated with myopia.

Details

Title
A Cross-Sectional Observational Study of the Relationship between Outdoor Exposure and Myopia in University Students, Measured by Conjunctival Ultraviolet Autofluorescence (CUVAF)
Author
Bilbao-Malavé, Valentina 1 ; González-Zamora, Jorge 1 ; Gándara, Elsa 2 ; de la Puente, Miriam 1 ; Escriche, Elena 3 ; Bezunartea, Jaione 4 ; Marizkurrena, Ainara 2 ; Alonso, Elena 5 ; Hernández, María 5 ; Fernández-Robredo, Patricia 5 ; Manuel Sáenz de Viteri 5   VIAFID ORCID Logo  ; Barrio-Barrio, Jesús 5   VIAFID ORCID Logo  ; García-Layana, Alfredo 5 ; Recalde, Sergio 5   VIAFID ORCID Logo 

 Department of Opthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain; [email protected] (V.B.-M.); [email protected] (J.G.-Z.); [email protected] (E.G.); [email protected] (M.d.l.P.); [email protected] (J.B.); [email protected] (A.M.); [email protected] (E.A.); [email protected] (M.H.); [email protected] (M.S.d.V.); [email protected] (J.B.-B.); [email protected] (A.G.-L.); [email protected] (S.R.); Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, 31008 Pamplona, Spain 
 Department of Opthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain; [email protected] (V.B.-M.); [email protected] (J.G.-Z.); [email protected] (E.G.); [email protected] (M.d.l.P.); [email protected] (J.B.); [email protected] (A.M.); [email protected] (E.A.); [email protected] (M.H.); [email protected] (M.S.d.V.); [email protected] (J.B.-B.); [email protected] (A.G.-L.); [email protected] (S.R.) 
 Faculty of Medicine, Universidad de Navarra, 31008 Pamplona, Spain; [email protected] 
 Department of Opthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain; [email protected] (V.B.-M.); [email protected] (J.G.-Z.); [email protected] (E.G.); [email protected] (M.d.l.P.); [email protected] (J.B.); [email protected] (A.M.); [email protected] (E.A.); [email protected] (M.H.); [email protected] (M.S.d.V.); [email protected] (J.B.-B.); [email protected] (A.G.-L.); [email protected] (S.R.); Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain; Red Temática de Investigación Cooperativa en Salud (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, 28029 Madrid, Spain 
 Department of Opthalmology, Clínica Universidad de Navarra, 31008 Pamplona, Spain; [email protected] (V.B.-M.); [email protected] (J.G.-Z.); [email protected] (E.G.); [email protected] (M.d.l.P.); [email protected] (J.B.); [email protected] (A.M.); [email protected] (E.A.); [email protected] (M.H.); [email protected] (M.S.d.V.); [email protected] (J.B.-B.); [email protected] (A.G.-L.); [email protected] (S.R.); Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Universidad de Navarra, 31008 Pamplona, Spain; Navarra Institute for Health Research, IdiSNA, 31008 Pamplona, Spain; Red Temática de Investigación Cooperativa en Salud (RD16/0008/0011), Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, 28029 Madrid, Spain 
First page
4264
Publication year
2022
Publication date
2022
Publisher
MDPI AG
e-ISSN
20770383
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2700640059
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.